Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10878359rdf:typepubmed:Citationlld:pubmed
pubmed-article:10878359lifeskim:mentionsumls-concept:C0004561lld:lifeskim
pubmed-article:10878359lifeskim:mentionsumls-concept:C0017337lld:lifeskim
pubmed-article:10878359lifeskim:mentionsumls-concept:C0678226lld:lifeskim
pubmed-article:10878359lifeskim:mentionsumls-concept:C1422424lld:lifeskim
pubmed-article:10878359lifeskim:mentionsumls-concept:C0815089lld:lifeskim
pubmed-article:10878359lifeskim:mentionsumls-concept:C1511695lld:lifeskim
pubmed-article:10878359lifeskim:mentionsumls-concept:C1517945lld:lifeskim
pubmed-article:10878359pubmed:issue2lld:pubmed
pubmed-article:10878359pubmed:dateCreated2000-8-3lld:pubmed
pubmed-article:10878359pubmed:abstractTextThe V kappa10 family of murine light chain Ig genes is composed of three members, two of which (V kappa 10A and V kappa 10B) are well used. V kappa 10C, the third member of this family, is not detected in any expressed Abs. Our previous work showed that V kappa 10C is structurally functional and can recombine, but mRNA levels in spleen were extremely low relative to those of V kappa 10A and V kappa 10B. Furthermore, while the V kappa 10C promoter was efficient in B cells, it was shown to work inefficiently in pre-B cell lines. Here, we extend our analysis of the V kappa 10 family and examine V kappa 10 gene accessibility, their representation in V kappa cDNA phage libraries, and the frequency and nature of rearrangements during different stages of B cell development. We demonstrate that V kappa 10C is under-represented in V kappa cDNA libraries, but that the frequency of its sterile transcripts in pre-B cells surpasses both V kappa 10A and V kappa 10B, indicating that the gene is as accessible as V kappa 10A and V kappa 10B to the recombination machinery. We also demonstrate that V kappa 10C recombines at a frequency equal to that of V kappa 10A in pre-B cells and has a normal nonproductive to productive recombination ratio. As B cells develop, however, both the frequency of V kappa 10C rearrangements and the presence of productive rearrangements decline, indicating that these cells are in some fashion being eliminated.lld:pubmed
pubmed-article:10878359pubmed:languageenglld:pubmed
pubmed-article:10878359pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10878359pubmed:citationSubsetAIMlld:pubmed
pubmed-article:10878359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10878359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10878359pubmed:statusMEDLINElld:pubmed
pubmed-article:10878359pubmed:monthJullld:pubmed
pubmed-article:10878359pubmed:issn0022-1767lld:pubmed
pubmed-article:10878359pubmed:authorpubmed-author:ShapiroM AMAlld:pubmed
pubmed-article:10878359pubmed:authorpubmed-author:ClarkK JKJlld:pubmed
pubmed-article:10878359pubmed:authorpubmed-author:MostowskiH...lld:pubmed
pubmed-article:10878359pubmed:authorpubmed-author:FitzsimmonsS...lld:pubmed
pubmed-article:10878359pubmed:issnTypePrintlld:pubmed
pubmed-article:10878359pubmed:day15lld:pubmed
pubmed-article:10878359pubmed:volume165lld:pubmed
pubmed-article:10878359pubmed:ownerNLMlld:pubmed
pubmed-article:10878359pubmed:authorsCompleteYlld:pubmed
pubmed-article:10878359pubmed:pagination852-9lld:pubmed
pubmed-article:10878359pubmed:dateRevised2005-11-17lld:pubmed
pubmed-article:10878359pubmed:meshHeadingpubmed-meshheading:10878359...lld:pubmed
pubmed-article:10878359pubmed:meshHeadingpubmed-meshheading:10878359...lld:pubmed
pubmed-article:10878359pubmed:meshHeadingpubmed-meshheading:10878359...lld:pubmed
pubmed-article:10878359pubmed:meshHeadingpubmed-meshheading:10878359...lld:pubmed
pubmed-article:10878359pubmed:meshHeadingpubmed-meshheading:10878359...lld:pubmed
pubmed-article:10878359pubmed:meshHeadingpubmed-meshheading:10878359...lld:pubmed
pubmed-article:10878359pubmed:meshHeadingpubmed-meshheading:10878359...lld:pubmed
pubmed-article:10878359pubmed:meshHeadingpubmed-meshheading:10878359...lld:pubmed
pubmed-article:10878359pubmed:meshHeadingpubmed-meshheading:10878359...lld:pubmed
pubmed-article:10878359pubmed:meshHeadingpubmed-meshheading:10878359...lld:pubmed
pubmed-article:10878359pubmed:meshHeadingpubmed-meshheading:10878359...lld:pubmed
pubmed-article:10878359pubmed:meshHeadingpubmed-meshheading:10878359...lld:pubmed
pubmed-article:10878359pubmed:meshHeadingpubmed-meshheading:10878359...lld:pubmed
pubmed-article:10878359pubmed:meshHeadingpubmed-meshheading:10878359...lld:pubmed
pubmed-article:10878359pubmed:meshHeadingpubmed-meshheading:10878359...lld:pubmed
pubmed-article:10878359pubmed:meshHeadingpubmed-meshheading:10878359...lld:pubmed
pubmed-article:10878359pubmed:meshHeadingpubmed-meshheading:10878359...lld:pubmed
pubmed-article:10878359pubmed:year2000lld:pubmed
pubmed-article:10878359pubmed:articleTitleUnderutilization of the V kappa 10C gene in the B cell repertoire is due to the loss of productive VJ rearrangements during B cell development.lld:pubmed
pubmed-article:10878359pubmed:affiliationDivision of Monoclonal Antibodies and Division of Cellular and Gene Therapies, Food and Drug Administration, Center for Biologics Evaluation and Research, Rockville, MD 20852, USA. fitzsimmons@cber.fda.govlld:pubmed
pubmed-article:10878359pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:434031entrezgene:pubmedpubmed-article:10878359lld:entrezgene